Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Affiliation country
Publication year range
1.
J Org Chem ; 78(22): 11318-25, 2013 Nov 15.
Article in English | MEDLINE | ID: mdl-24199599

ABSTRACT

A series of donor-acceptor systems incorporating a carbazole moiety as the donating unit and pyridine moiety as the accepting unit have been designed and synthesized. The spectroscopic and electrochemical behaviors of the carbazole derivatives demonstrate that the carbazole unit interacts with the electron-accepting group through the π-conjugated spacer, thus leading to the intramolecular charge transfer (ICT). The pyridine-substituted carbazole derivatives show significant sensing and coordinating properties toward a wide range of metal cations. Compound S2 exhibits fluorescence enhancement upon association with transition metal cations, and compound V3 shows high selectivity for Cu(2+) among this series of materials. DFT calculations indicate the different association abilities of the dyes and the enhancement of ICT upon addition of the metal cations.

2.
Guang Pu Xue Yu Guang Pu Fen Xi ; 29(8): 2096-8, 2009 Aug.
Article in Zh | MEDLINE | ID: mdl-19839316

ABSTRACT

The present paper reports theoretical and experimental research on the tunable output characteristics of periodically polarized lithium niobate. We made six equal distance crystal grating sections, with each distance being 0.5 mm and the polarization period range of 29.0-31.5 mm. Especially, at room temperature, the signal-wavelength tunable output in the range of 1 449.7-1 665.0 nm and idle-wavelength tunable output in the range of 3 989.2-2 946.0 nm were achieved by LD end-pumped Nd : YVO4 laser with Q-switch in sound-wave. The lowest excitation threshold was 108.0 mW, while the highest excitation threshold was 149.2 mW. When the pump power was 649 mW, the highest gained signal-wave output was 118.5 mW and its conversion efficiency was 18.26%. Meanwhile, the idle-wave output was 46.6 mW and its conversion efficiency was 7.18%. These parameters approached the practicality level.

3.
Gene ; 540(2): 232-7, 2014 May 01.
Article in English | MEDLINE | ID: mdl-24561286

ABSTRACT

AIM: Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer death worldwide. This study aims to explore the molecular mechanism of PDAC and identify biologically active small molecules capable of targeting the sub-pathways which were dysregulated in the development of PDAC. METHODS: The gene expression profile of GSE28735 microarray data (including 45 matching pairs of pancreatic tumor and adjacent non-tumor tissues) was downloaded from GEO (Gene Expression Omnibus) database. Differentially expressed genes (DEGs) between pancreatic tumor tissues and non-tumor tissues were identified, and then the sub-pathway enrichment analysis was performed. Moreover, an approach based on targeting sub-pathways was used to reveal potential agents for PDAC. RESULTS: A total of 5315 DEGs were identified between pancreatic tumor tissues and non-tumor tissues with a false discovery rate of 0.01. Genes of collagen family and integrin receptor family which were involved in pathways of focal adhesion and ECM-receptor interaction respectively were differentially expressed in the pancreatic tumor tissue. Besides, a total of 85 small molecules including fludrocortisone, latamoxef and metronidazole were revealed by bioinformatics analysis. CONCLUSION: This study proposed the use of an approach based on targeting sub-pathways to identify potential agents for PDAC. The sub-pathways and small molecules discovered in this study were not only related to PDAC but also play a role in perturbing the development of PDAC.


Subject(s)
Carcinoma, Pancreatic Ductal/metabolism , Pancreatic Neoplasms/metabolism , Antineoplastic Agents/pharmacology , Carcinoma, Pancreatic Ductal/drug therapy , Carcinoma, Pancreatic Ductal/genetics , Collagen/genetics , Collagen/metabolism , Gene Expression Regulation, Neoplastic , Humans , Integrins/genetics , Integrins/metabolism , Metabolic Networks and Pathways , Molecular Targeted Therapy , Oligonucleotide Array Sequence Analysis , Pancreatic Neoplasms/drug therapy , Pancreatic Neoplasms/genetics , Transcriptome
SELECTION OF CITATIONS
SEARCH DETAIL